GLP1R ligand-SOD1 RNAi(Arrowhead)

N/A

Report date: 2026/04/10 15:46:37
NME

Base Information

Drug NameGLP1R ligand-SOD1 RNAi(Arrowhead)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Small Molecule-Drug Conjugates
Mechanisms of ActionGlucagon-like peptide 1 receptor modulatorsSuperoxide dismutase modulators
TargetsGlucagon-like peptide 1 receptorSuperoxide dismutase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A